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Proteolytic enzymes have fascinated workers not 
only because of the information one gleans about the 
nature of proteases themselves, but also because they 
form important adjuncts to the arsenal of the bio- 
chemist working in almost all other areas of biological 
research. To the dedicated scientist worshipping his 
Muse, rewards have been rapidly showered. Proteases 
were among the first enzymes to be purified and 
crystallized, and this helped pave way for the eventual 
understanding of protein structure and of the catalytic 
sites on different enzymes. Molecular understanding 
of biological phenomenon owes much to the use of 
proteases and protease inhibitors used as tools to 
dissect cellular processes. It has become increasingly 
evident that partial proteolysis is of very wide occur- 
rence and that the key lies in delineating the mecha- 
nisms whereby the scope of proteolytic action is 
limited in time and space. 
An earlier publication [ 1 ] has already explored 
the role of proteases in blood coagulation, comple- 
ment activation, fibrinolysis, tumorogenesis, repro- 
duction, cell growth, and selected other cellular 
aspects, although this is not an exhaustive list of 
topics that could have been covered at that time since 
proteolytic control was known in several other bio- 
logical systems. Since then, the list of physiological 
levels of regulation sensitive to partial proteolysis has 
lengthened considerably. Thus, activation of renin 
precursor [2], thrombin-stimulated cell division [3], 
hormone-receptor interaction [4], cyclase modula- 
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tion [5,6] are more recent examples of regulation by 
proteases and proteinase inhibitors. The advances in 
the in vitro properties and isolation of acid and 
neutral proteinases, and of protease inhibitors of 
microbial origin, too, have been rapid [7]. The time 
was therefore ripe to analyze the issues for future 
conceptual and practical attack. 
The workshop in Munich brought together workers 
in very diverse areas with a view to confronting the 
individual investigator with one theme comprising 
conceptual and technical advances in related topics, 
the only common point being the regulation of these 
systems, at one point or another, by proteinases or 
their inhibitors. Professor Keil (Paris) kindly reviewed 
the current status of proteolytic enzyme structure 
and function, as well as the nature of different protease 
inhibitors, including microbial protease inhibitors 
isolated just a decade or so ago and which are now on 
the shelves of most investigators active in this area. 
Although the structure and action of extracellular 
proteinases is known in detail in many cases, the 
understanding of the initiation of their synthesis in 
pro- and eucaryotes is relatively poor. Only four 
types of active sites on proteinase protein are currently 
known and each newly discovered proteolytic enzyme 
is assigned to one of these categories, thus simplifying 
the task of finding, by analogy, an efficient inhibitor 
for the proteinase in question. Furthermore, endo- 
peptidases attack only selected amino acid residues in 
proteins thereby raising the problem of control 
during regulatory proteolysis. 
Professor Hales (Cambridge) suggested that the 
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very fact of specificity of proteolytic enzyme attack 
sites (lysine or arginine for trypsin; pheny~l~~e or 
tyrosine for chymotryp~n), further confirmed by 
the specificity of inhibitor action (serine residues for 
lima bean trypsin inhibitor), would a priori exclude 
the hypothesis that sensitivity to proteolytic attack is 
simply a question of the number of such sites on the 
nonprotease protein. Rather, control must exist to 
limit access to the sensitive site, possibly by pairs or 
groups of basic amino acids as sites of initiation of 
endoproteolytic cleavage inprohormones. The obvious 
question was raised (Ryan) whether the number of 
serine residues could be related to the extent of 
proteolysis but this has not yet been experimenta~y 
substantiated (Keil). A curious observation isthe fact 
that proteolytic activation in almost all systems on 
record seems to be accomplished by endopeptidases, 
the ends of chains being protected in some manner 
from attack by amino- or carboxy~ptidases (Agarwal). 
during certain types of clinical pathology. It was 
pointed out (Agarwal) that the influence of microbial 
protease inhibitors (such as leupeptins) may tell us 
more not only about the mechanisms of coagulation 
but also its modulation during bacterial and other 
infections. 
The importance of the levels of proteolytic activity, 
in plasma nd in several tissues, in the phy~olo~cal 
well being of the host was discussed by Dr Soria 
(Paris) using prekallikrein-kallikrein system as a 
model. For example, low plasma kallikrein levels are 
responsible for clotting abnormalities (Hageman 
factor-dependent) at a time when blood clotting 
factors are in the normal range. Tissue (kidney, pan- 
creas, salivary gland) kallikrein levels, too, in certain 
cases, can be correlated with the onset of altered 
diuresis and hypertension. 
In order to account for the genesis of polypeptide 
hormones from biologicaIly inactive prepro- and pro- 
proteins, Professor Hales presented evidence that the 
evolutionary origin of protein hormones is by 
lysosomal proteolysis. In lysosomes, after macro- 
molecular degradation, the smaller components must 
enter the lysosomal membrane, possibly by the inter- 
vention of transport processes, although alteration of 
membrane permeability by dimethylsulfoxide did not 
affect the facilitated iffusion analyzed under these 
conditions. This evolutionary argument (Hales) 
envisages that mother nature took advantage of the 
protein fragments hat existed uring the evolutionary 
sequence and converted them to hormones with utmost 
economy to the host. This is supported by the existence 
of lactation factors in fish as well as mammals that 
these organisms are currently not using (Keil). 
Somatomedin B is an acidic, single chain peptide 
(5000 mol. wt) without structural homology to 
growth factors or insulin, but endowed with insulin- 
like and growth promoting properties (Forsman). It 
also exhibits weak trypsin inhibitory activity and is 
resistant to proteolytic attack. Its structural homology 
with some protease inhibitors, its lack of effect 
in vitro, and its stimulatory influence on DNA synthesis 
in glial cells in vivo, would all suggest that its action 
is based on the antiproteolytic property, similar to 
other protease inhibitors [3]. 
Thus, human pathology may be related both with 
the levels of plasma or tissue proteases (Heimburger, 
Soria) as well as protease ~~bitors (Fryklund, 
Heimburger), all of endogenous origin and, as sug- 
gested earlier (Agarwal), the effect of microbial 
protease inhibitors on mammalian physiology in vivo 
would be of obvious interest. 
Professor ~eimburger (~arburg/~) reviewed The second part of the workshop focussed attention 
the current status of the control of blood coagulation on two recently described systems that have never 
by proteinase inhibitors. Approximately 20 different been discussed in a similar forum before. Professor 
plasma glycoproteins are known to be involved in the Fanestil (San Diego) has used a number of different 
cascade of blood coagulation control, most of which cell types and tissues to suggest that the steroid 
are synthesized in the liver; some are enzymes, others recognition site on the receptor for all classes of 
are catalysts, and still others are substrates and/or steroid hormones contains common structural features 
inhibitors. Again, all enzymes are endopeptidases. which allow recognition by various protease inhibitors 
The protease inhibitors are: antithrombin III (equiv- and substrates, via competitive inhibition of the 
alent to heparin); a2-macroglobulin; cwl-antitrypsin. hormone-receptor binding. Dr Wrange (Stockholm) 
Coagulation can also be activated by lysosomal demonstrated progressive fragmentation of the liver 
proteases whose plasma concentration may vary glucocorticoid receptor by a number of common 
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lysosomal enzymes. The glucocorticoid receptor can 
be cleaved into a form incapable of binding to DNA 
and another that accepts the steroid on a mole per 
mole basis. This sequence can be inhibited by gelation 
but not by specific protease inhibitors (leupeptins, 
antipain) that have been successfully used by others 
to demonstrate he inhibition of steroid-receptor 
binding; phospho~pases-phosphatidylcho~ne systems, 
too, were ineffective in their study, although active 
in the mouse fibroblast in studies by others. A long 
discussion ensued and it was agreed that the variability 
of techniques and tissues, used by different investiga- 
tors, rules out meaningful comparisons. The point 
was raised whether the proteases and inhibitors are 
directIy affecting the receptor or a transformation 
factor in the cytoplasm that is believed to modify the 
receptor (Agarwal) but again no consensus could be 
reached. 
Agarwal et al. presented their multipolar model 
that calls for the preferential saturation of only a 
part of the complex, heterogeneous, polymorphic 
ligand, by a given steroid in the tissue in question, 
leaving other sites free to concurrently accept other 
signals. This is in contrast o the classical model of 
ph~macolo~ where all grades of agonist and antag- 
onist activity are expressed via interaction with the 
one and the same protein vector. The possibility was 
therefore ntertained that multiplicity may be an 
expression of regulatory proteolysis. The effec- 
tiveness of papain, trypsin and chymotrypsin, in 
decreasing ho~one-receptor b~d~g, is dependent 
upon the steroid used to saturate the vector; thus 
renal progesterone versus aldosterone binding did 
not respond in the same manner. Similarly, lima 
bean trypsin inhibitor and e-aminocaproic a id did 
not affect gluco- or mineraio- receptor-steroid binding 
but both increased liver estrogen and decreased liver 
androgen binding. Leupeptin almost completely 
eliminated liver cortisol binding, did not influence 
kidney aldosterone binding, increased liver androgen 
binding, but decreased hepatic estrogen binding. 
Multip~city of liver gluco- and renal mineralo- corticoid 
peaks till persisted in ~hromato~aphy after inclusion 
of proteases or their inhibitors during cytosol prepara- 
tion and all subsequent s eps. Thus, multipolarity of 
the steroid hormone receptor would appear to be an 
inherent property of the cellular vector necessary for 
physiological ctivity of the signal [8,9]. 
Professor Ryan (Rochester) presented a particularly 
provoking model according to which proteases may 
be involved in the coupling mechanism between 
hormone receptors and adenylate cyclase. In their 
two step model, low concentrations of protease 
inhibitors irreversibly affect the pathway of hormonal 
stimulation whereas adirect influence on the initial 
velocity of adenylate cyclase is envisaged with higher 
concentrations of protease inhibitors. In the ensuing 
discussion (Agarwal) it was pointed out that bacterial 
cyclase is not influenced by bacterial protease inhibitors 
that have been used with such wonderful effectiveness 
in mamma~an systems. Does this signify that bacteria 
have developed mechanisms of protection in physio- 
logical reactions which could otherwise be modulated 
by endogenous protease inhibitors? If so, what are 
the mechanisms of regulation in bacteria of those 
physiological reactions that, in the mammal, are sub- 
ject to regulation by bacterial protease in~bito~? 
Surp~sin~y still, no one has studied the effect of 
mammalian protease inhibitors (macroglobulins, 
somatomedins) onthose reactions (cyclases for instance) 
that are subject o regulation by microbial protease 
inhibitors. Thus, the physiological meaning of studies 
with microbial protease in~bito~ remains in suspense. 
Working along the same lines as Dr Anderson 
(Bethesda) who was not present, he group of 
Dr Hanoune (Creteil) strived to piece together 
concurrent evidence that rat liver or turkey erythrocyte 
membrane adenylate cyclase and guanylate cyclase 
systems could be activated by various proteolytic 
enzymes of mammalian origin in the in vitro assays. 
The authors were clearly ill prepared to handle the 
discussion both conceptually and from the technical 
angle. Thus, it was not clear whether solvent controls 
were used since ethanol itself can increase hormonal 
respon~veness of cyclases, possibly by loosening the 
membranes initially to facilitate receptor movement, 
following which inhibition may ensue (Ryan). Again, 
no comments could be obtained when asked about 
the specificity of activation by the different proteolytic 
enzymes, especially in view of mitotic striation 
under similar conditions. If such in vitro studies have 
some in vivo relevance (Agarwal), one would expect 
changes in cyclase activity during those conditions 
(stress, pancreatitis, and many others) where the 
lyososomal content of plasma is known to increase, 
coagulation alteration under these conditions being 
3 
Volume 106, number 1 FEBS LETTERS October 1979 
already well documented (Heimburger). Coming to 
their rescue, Ryan indicated that there are a lot of 
proteases and protease inhibitors floating around in 
different tissues in varying concentrations and, 
despite some advance [7], one has not even touched 
the surface of the problem as yet. 
Lack of time heralded the end of the discussion. 
Some thoughts for future trends would include: 
assessment of signals on the nonprotease, and even 
the protease, peptide that limit proteolysis in space 
and in time, especially in view of the fact that papain, 
the most active proteolytic enzyme, is not of animal 
origin; the influence of microbial protease inhibitors 
on various systems in the host in vivo in relation to 
the role of endogenous inhibitors on the very same 
processes; correlations between the levels of circulating 
or tissue proteases and the extent of activation of the 
protease-sensitive process; the role of amino- and 
carboxypeptidases and the mechanisms whereby 
endopeptidase-sensitive processes are resistant to 
exopeptidase attack, even after partial cleavage by the 
former. 
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